Literature DB >> 4966953

The antimycobacterial activity of rifampin.

G L Hobby, T F Lenert.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 4966953     DOI: 10.1164/arrd.1968.97.4.713

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  8 in total

1.  Permeability barrier to rifampin in mycobacteria.

Authors:  J Hui; N Gordon; R Kajioka
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

Review 2.  Pulmonary tuberculosis: evolution of modern therapy.

Authors:  M B Rosenblatt
Journal:  Bull N Y Acad Med       Date:  1973-03

3.  Sensitivity of some mycobacteria to Rifocin-M.

Authors:  P Cavanagh
Journal:  Br Med J       Date:  1969-02-01

4.  Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis.

Authors:  S H Siddiqi; A Aziz; Z Reggiardo; G Middlebrook
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

Review 5.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

6.  Susceptibility of mycobacteria to rifampin.

Authors:  C L Woodley; J O Kilburn; H L David; V A Silcox
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

7.  In vitro effect of rifampin on mycobacteria.

Authors:  V Lorian; M Finland
Journal:  Appl Microbiol       Date:  1969-02

8.  Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions.

Authors:  K D Stottmeier; G P Kubica; C L Woodley
Journal:  Appl Microbiol       Date:  1969-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.